Drugs / [18F]Fluoropivalate
[18F]Fluoropivalate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04717674 | Dec 2021 → Aug 2024 | cancer | University College, London | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [18F]Fluoropivalate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04717674 ↗ |
| Known as | [18F]Fluoro-2,2-Dimethylpropionic Acid | “[18F]Fluoropivalate ([18F]Fluoro-2,2-Dimethylpropionic Acid)” NCT04717674 ↗ |
| Known as | FPIA | “[18F]Fluoropivalate ([18F]Fluoro-2,2-Dimethylpropionic Acid) (FPIA)” NCT04717674 ↗ |
| Modality | Diagnostic / imaging agent | “PET/CT Imaging” NCT04717674 ↗ |